Move Forward 3D Motion Simulation Service

K162559 · Biomet, Inc. · LLZ · Mar 31, 2017 · Radiology

Device Facts

Record IDK162559
Device NameMove Forward 3D Motion Simulation Service
ApplicantBiomet, Inc.
Product CodeLLZ · Radiology
Decision DateMar 31, 2017
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.2050
Device ClassClass 2
AttributesSoftware as a Medical Device

Intended Use

The Move Forward 3D Motion Service is intended as pre-operative or post-operative software for simulating/evaluating hip preservation surgical treatment options and historical case review, respectively.

Device Story

Move Forward 3D Motion Simulation Service is an online image analysis service for hip joint evaluation. Input consists of patient CT or MR image data uploaded to the CGOnline module. Zimmer Biomet operators use internal software modules (Arbiter and Articulis) to perform image segmentation, creating 3D bone models of the pelvis and femur. The system performs 3D motion simulations to visualize bone contact and range of motion, calculates intersection zones, and computes morphological shape parameters. Output is an interactive PDF report delivered to clinicians (radiologists and orthopedic surgeons) to assist in pre-operative or post-operative planning for hip preservation surgery, specifically regarding femoroacetabular impingement (FAI). Clinicians do not interact with the software directly; the service is managed by trained company operators.

Clinical Evidence

No clinical data provided. Substantial equivalence is supported by non-clinical software verification and validation activities demonstrating safety and effectiveness comparable to the predicate device.

Technological Characteristics

Stand-alone software service; utilizes DICOM files from CT or MRI scanners. Features include image segmentation, 3D bone model rendering, motion simulation algorithms, and morphological parameter calculation. Delivered via online portal (CGOnline).

Indications for Use

Indicated for skeletally mature individuals to obtain 3D motion simulation reports based on CT or MR image data of hip joints for clinical evaluation.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines connecting them. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 March 31, 2017 Biomet, Inc. % Mr. Paul Hardy Regulatory Affairs Senior Specialist 56 East Bell Drive PO Box 587 WARSAW IN 46581 Re: K162559 Trade/Device Name: Move Forward 3D Motion Simulation Service Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: February 23, 2017 Received: February 24, 2017 Dear Mr. Hardy: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. Michael D.'Hara For Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K162559 Device Name Move Forward 3D Motion Simulation Service ### Indications for Use (Describe) Zimmer Biomet's Move Forward 3D Motion Simulation Service is an online image analysis service indicated for skeletally mature individuals that enables clinicians to obtain 3D motion simulation reports based on CT or MR image data. The service can be used by uploading either CT or MR image data of hip joints. The image data is processed by Zimmer Biomet to create 3D anatomy models. These 3D models are then used to perform 3D motion simulations of the hip joint. The report also provides several calculated intersection zones that may improve the simulated range of motion. Move Forward also calculates several morphological shape parameters for each of the 3D anatomy models. The software generates an interactive report as output. Clinicians do not interact with the image analysis software directly. The image analysis software is only operated by Zimmer Biomet operators who have been specifically trained for this purpose. End users of the generated Move Forward reports are trained medical professionals, including radiologists and orthopedic surgeons. | Type of Use (Select one or both, as applicable) | | |----------------------------------------------------------------------------------|----------------------------------------------------------------------| | <input checked="" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D) | <input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C) | # CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the word "BIOMET" in a bold, sans-serif font. The letters are dark gray, and the image has a slightly blurred effect. The word appears to be a logo or brand name. # 510(k) Summary In accordance with 21 CFR §807.92 and the Safe Medical Devices Act of 1990, the following information is provided for the Move Forward 3D Motion Simulation Service 510(k) premarket notification. The submission was prepared in accordance with the FDA guidance document, 'Format for Traditional and Abbreviated 510(k)s', issued on August 12, 2005. | Sponsor: | Biomet, Inc.<br>56 East Bell Drive<br>PO Box 587<br>Warsaw, IN 46581<br>Establishment Registration Number: 1825034 | |-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Contact: | Paul Hardy<br>Regulatory Affairs Senior Specialist<br>574-372-6799 | | Date: | February 22, 2017 | | Subject Device: | Trade Name: Move Forward 3D Motion Simulation Service<br>Common Name: Hip impingement image analysis system<br>Classification Name:<br>• LLZ- Picture Archive and Communications System (PACS) (21 CFR<br>892.2050) | # Legally marketed devices to which substantial equivalence is claimed: - Dyonics Plan Hip Impingement Planning Software manufacturered by Smith & Nephew (K132636) ### Device Description The Move Forward 3D Motion Simulation Service is an online image analysis service that enables clinicians to obtain 3D motion simulation reports based on CT or MR image data. This service consists of three modules: CGOnline, Arbiter, and Articulis. During the segmentation process, 3D bone models of the pelvis and femur bones are created from the image data. Any required editing of the segmentation images are performed by Zimmer Biomet operators. These 3D bone models are then used to perform 3D motion simulations of the hip joint. The 3D motion simulations can be used to visualize rigid shapes such as bones that come into contact with one another, thus potentially limiting range of motion. The system includes several calculated intersection zones that each individually improve the simulated range of motion. The system also calculates several morphological shape parameters for each of the 3D bone models. {4}------------------------------------------------ The software generates an interactive PDF report as output, which Zimmer Biomet delivers to clinicians on a per case basis through the CGOnline module. In particular, the report that is generated provides information to the clinicians associated with femoroacetabular impingement (FAI). Clinicians do not interact with the image analysis software directly. The Articulis and Arbiter modules are only operated by Zimmer Biomet operators who have been specifically trained for this purpose. End users of the generated Move Forward reports are trained medical professionals, including radiologists and orthopedic surgeons. # Indications for Use Zimmer Biomet's Move Forward 3D Motion Simulation Service is an online image analysis service indicated for skeletally mature individuals that enables clinicians to obtain 3D motion simulation reports based on CT or MR image data. The service can be used by uploading either CT or MR image data of hip joints. The image data is processed by Zimmer Biomet to create 3D anatomy models. These 3D models are then used to perform 3D motion simulations of the hip joint. The report also provides several calculated intersection zones that may improve the simulated range of motion. Move Forward also calculates several morphological shape parameters for each of the 3D anatomy models. The software generates an interactive report as an output. Clinicians do not interact with the image analysis software directly. The image analysis software is only operated by Zimmer Biomet operators who have been specifically trained for this purpose. End users of the generated Move Forward reports are trained medical professionals, including radiologists and orthopedic surgeons. # Intended Use The Move Forward 3D Motion Service is intended as pre-operative or post-operative software for simulating/evaluating hip preservation surgical treatment options and historical case review, respectively. # Summary of Technological Characteristics The rationale for substantial equivalence is based on consideration of the following characteristics: - Indications for Use: The Dyonics Plan Hip Impingement Planning System software is intended for use as a software interface and image segmentation system for the transfer of imaging information from a medical scanner such as a CT scanner to an output file. It is also intended as pre-operative or post-operative software for simulating/evaluating hip preservation surgical treatment options and historical case review, respectively. - . Intended Use: The Dyonics Plan is intended as a pre-operative or post-operative software for simulating/evaluating hip preservation surgical treatment options and historical case review respectively. - Design Features: Stand-alone software packages that have the following features: {5}------------------------------------------------ Image /page/5/Picture/0 description: The image shows the word "BIOMET" in a bold, sans-serif font. The letters are dark gray, and the word is slightly elongated horizontally. The overall impression is of a clean and modern design. - Input files consist of DICOM files from CTs for Dyonics and CTs and MRIs for 3D O Move Forward Simulation Service - o The proposed and predicate device both provide image processing tools including image segmentation and 3D rendering tools - The proposed and predicate device both have tools for surgical simulation and O planning - The proposed device allows for the display of anatomical parameters which the o predicate device also provides for anatomical parameters. - The proposed and predicate device provide an output report which can be O referenced pre-operatively, post-operatively, and inter-operatively - The proposed and predicate device provide range of motion simulations o ## Summary of Performance Data (Nonclinical and/or Clinical) - . Non-Clinical Tests - o Software Verification and Validation activities demonstrate that the Move Forward 3D Motion Simulation Service does not raise any new issues of safety and effectiveness as compared to the predicate device. ## Substantial Equivalence Conclusion The differences between the proposed and predicate device do not introduce new types of safety and effectiveness questions. The Move Forward 3D Motion Simulation Service is substantially equivalent to the Dyonics Plan software and the intended uses are identical.
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...